BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16960922)

  • 1. Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001.
    Knight A; Ekbom A; Brandt L; Askling J
    J Rheumatol; 2006 Oct; 33(10):2060-3. PubMed ID: 16960922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
    Zhang X; Jiang M; Chui J; Wang H; Ma J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Wegener's granulomatosis in the ANCA era.
    Al Maini M; Carette S
    J Rheumatol; 2006 Oct; 33(10):1923-5. PubMed ID: 17014008
    [No Abstract]   [Full Text] [Related]  

  • 4. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
    Gibson A; Stamp LK; Chapman PT; O'Donnell JL
    Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Wegener's granulomatosis in northern Norway.
    Koldingsnes W; Nossent H
    Arthritis Rheum; 2000 Nov; 43(11):2481-7. PubMed ID: 11083271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
    Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
    Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
    Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
    Comfere NI; Macaron NC; Gibson LE
    J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?
    Gatenby PA; Lucas RM; Engelsen O; Ponsonby AL; Clements M
    Arthritis Rheum; 2009 Oct; 61(10):1417-24. PubMed ID: 19790114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wegener's granulomatosis in 2 adolescents].
    van der Aa LB; van der Heide M; Sprikkelman AB; Brinkhorst G; Tytgat GA; van den Berg JM
    Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1522-6. PubMed ID: 17763812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wegener's granulomatosis.
    Yi ES; Colby TV
    Semin Diagn Pathol; 2001 Feb; 18(1):34-46. PubMed ID: 11296992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
    Zhou Y; Huang D; Farver C; Hoffman GS
    J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
    Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
    Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wegener's granulomatosis associated with renal cell carcinoma.
    Tatsis E; Reinhold-Keller E; Steindorf K; Feller AC; Gross WL
    Arthritis Rheum; 1999 Apr; 42(4):751-6. PubMed ID: 10211890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis.
    Lin P; Bhullar SS; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2008 Mar; 145(3):463-471. PubMed ID: 18061135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wegener's granulomatosis--clinical analysis of 18 patients group.
    Dabrowski A; Droszcz W
    Med Sci Monit; 2000; 6(1):151-7. PubMed ID: 11208304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of highly sensitive C-reactive protein for followup of Wegener's granulomatosis.
    Kälsch AI; Csernok E; Münch D; Birck R; Yard BA; Gross W; Kälsch T; Schmitt WH
    J Rheumatol; 2010 Nov; 37(11):2319-25. PubMed ID: 20716656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
    Lurati-Ruiz F; Spertini F
    J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
    Chen M; Yu F; Wang SX; Zou WZ; Zhang Y; Zhao MH; Wang HY
    Nephrol Dial Transplant; 2007 Jan; 22(1):139-45. PubMed ID: 16980322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.